Bristol-Myers To Divest Mead Johnson Stake
Bristol-Myers Squibb Co. has said it plans to split off its 83 percent stake in infant-formula maker Mead Johnson Nutrition Co., a move the drugmaker said will allow it to focus...To view the full article, register now.
Already a subscriber? Click here to view full article